biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > S&P Biotech ETF now down 38% this year alone

<< Previous

Bullboard Posts

Next >>

Comment by fatboy92on May 07, 2022 12:31pm

161 Views

Post# 34664499

RE:RE:RE:S&P Biotech ETF now down 38% this year alone

Awe I upset Beenthere. I really hit a nerve replying to your only buddy. I know when he only gets one thumbs up, its from you his faithful lap dog...dummy you should reread your post and realize how stupid you sound and maybe you should ask yourself the same question. Ps...the way it goes is if you don't want to read what I say then you put me on ignore you pathetic moron.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario